首页
400-620-6333
凋亡
选项
-
脱羧氯雷他定CAS号: 100643-71-8分子式: C19H19ClN2 分子量: 310.83IUPAC Name: 13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaeneSMILES: C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4InChIKey: JAUOIFJMECXRGI-UHFFFAOYSA-NInChI: 1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2
-
-
盐酸尼莫司汀CAS号: 55661-38-6分子式: C9H13ClN6O2·HCl 分子量: 309.15IUPAC Name: 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea;hydrochlorideSMILES: CC1=NC=C(C(=N1)N)CNC(=O)N(CCCl)N=O.ClInChIKey: KPMKNHGAPDCYLP-UHFFFAOYSA-NInChI: 1S/C9H13ClN6O2.ClH/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10;/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14);1H
-
-
Se-(甲基)硒基-L-半胱氨酸CAS号: 26046-90-2 Compound CID : 147004分子式: C4H9NO2Se 分子量: 182.08IUPAC Name: (2R)-2-amino-3-methylselanylpropanoic acidSMILES: C[Se]CC(C(=O)O)NInChIKey: XDSSPSLGNGIIHP-VKHMYHEASA-NInChI: 1S/C4H9NO2Se/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1
-
S-(羧甲基)-L-半胱氨酸分子式: C5H9NO4S 分子量: 179.19IUPAC Name: (2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acidSMILES: N[C@@H](CSCC(O)=O)C(O)=OInChIKey: GBFLZEXEOZUWRN-VKHMYHEASA-NInChI: 1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1
-
Ozoralizumab (anti-TNF-alpha&HSA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1167985-17-2
-
Brentuximab vedotin (anti-CD30)关联靶标: TNFRSF8简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 914088-09-8SMILES: [Brentuximab vedotin]
-
Inezetamab (anti-CD40&MSLN)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1-EM-CGC; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1-EM-CGC宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2568264-76-4
-
Linvoseltamab (anti-BCMA&CD3)简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG4SP宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2408319-25-3
-
Remtolumab (anti-IL-17A&TNF-alpha)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1791410-27-9SMILES: [Remtolumab]
